# ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock

Study · id `cardio:ct-nct02301819` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02301819](<https://clinicaltrials.gov/study/NCT02301819>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02301819

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.

## Technical summary

Registry record NCT02301819. Randomized; single masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2022-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 122 participants (enrolled count; ClinicalTrials.gov record NCT02301819, source copy `cardio:ctgov-nct02301819-2023-04-05`, retrieved 2026-10-31)
- Start date: 2014-09 (registry gives no type) (ClinicalTrials.gov record NCT02301819, source copy `cardio:ctgov-nct02301819-2023-04-05`, retrieved 2026-10-31)
- Primary completion: 2022-08 (actual) (ClinicalTrials.gov record NCT02301819, source copy `cardio:ctgov-nct02301819-2023-04-05`, retrieved 2026-10-31)
- Completion: 2023-01 (actual) (ClinicalTrials.gov record NCT02301819, source copy `cardio:ctgov-nct02301819-2023-04-05`, retrieved 2026-10-31)
- Countries: Czechia (ClinicalTrials.gov record NCT02301819, source copy `cardio:ctgov-nct02301819-2023-04-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02301819-2023-04-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock
- Acronym: ECMO-CS
- Condition: Cardiogenic Shock
- Intervention (Device): Veno-arterial extracorporeal membrane oxygenation (ECMO)
- Intervention (Other): Early conservative therapy according to standard practice
- Lead sponsor: Na Homolce Hospital
- Lead sponsor class: OTHER
- Collaborator: General University Hospital, Prague
- Collaborator class: OTHER
- Collaborator: University Hospital Pilsen
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Registry lists this organization as a collaborator: General University Hospital, Prague (`cardio:org-general-university-hospital-prague`)
- Registry lists this organization as a collaborator: University Hospital Pilsen (`cardio:org-university-hospital-pilsen`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial (`cardio:pubmed-36335478`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cardiac index, SvO2 or pCO2 gap may determine benefit from ECMO in cardiogenic shock: post-hoc analysis of the multicenter, randomized ECMO-CS trial (`cardio:pubmed-40660350`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 350d9dc980fd665f2e0876bc34f96f564e6c09ae48cdd574bb2c840e2c602bce
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
